Inicio | Buscar

Buscar

Resultados de la búsqueda

Nasalferon en COVID-19

... Signal transduction in the interferon system. Seminars in Oncology. 1998; 25 (1 Suppl 1):14-22. 6. Nancy Au-Yeung, Roli Mandhana & ... K. Safety profile of interferon-alpha therapy. Seminars in Oncology. 1998; 25(1 Suppl 1): 9-13. 9. Lu NF, Huang AL, Tang N, et al. [An ...

Ensayos Clínicos - CIGB - 12/11/2021 - 12:08pm

CIMAvaxEGF/Cáncer de Pulmón/ Biomarcadores/EC prospectivo

... Society of Pathology and the Spanish Society of Medical Oncology. Clinical and Translational Oncology (2020) 22:989–1003 6. Rolfo C, Mack PC, Scagliotti GV, Baas P, ...

Ensayos Clínicos - CIM - 01/11/2021 - 8:59am

CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT

... MD, First Degree Specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 01/11/2021 - 8:59am

Gammaglobulina anti SARS-CoV-2

... Resolution. Am J Pathol. 2016;186(5):1066-77. oracic oncology : official publication of the International Association for the Study ...

Ensayos Clínicos - AICA - 29/10/2021 - 12:18pm

An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib

... Medical Doctor, First degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Dra. Yoanna Flores, Medical Doctor, First ...

Clinical Trials - ROCHE - 31/08/2021 - 9:58am

Un estudio observacional para evaluar el manejo clínico y los resultados en el mundo real de los participantes de CPCNP avanzado ALK positivos tratados con alectinib

... instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76. Arbour KC, Riely GJ. Diagnosis ... Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Non-Small Cell Lung Cancer. Version 3.2020 – 11 ...

Ensayos Clínicos - ROCHE - 31/08/2021 - 9:57am

CIMAvax-EGF vaccine Predictor Phase IV

... MD, First degree specialist in Oncology Affiliation:  ... , Juan Carlos Brosales, MD, First Degree Especilist in Oncology Havana, Luis Galván ...

Clinical Trials - CIM - 27/08/2021 - 10:39am

Vacuna CIMAvax-EGF Predictor fase IV

... NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I. 2013 www.nccn.org ...

Ensayos Clínicos - CIM - 26/08/2021 - 3:50pm

Estudio para evaluar la eficacia y la seguridad del tratamiento con quimioterapia más Atezolizumab en pacientes con cáncer de mama triple negativo recurrente recidivante temprano

... de funcionamiento del Eastern Cooperative Oncology Group 0-1 7. Esperanza de vida ≥ 12 semanas 8. Función ... instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76. Adams S, Diamond J, Hamilton E, ... for diagnosis, treatment and follow-up. Annals of Oncology 2012;23 (Supplement 7):vii11−vii19. Carey LA, Rugo HS, Marcom PK et ...

Ensayos Clínicos - ROCHE - 18/08/2021 - 6:06pm

Estudio para evaluar la preferencia de los pacientes y la satisfacción de la administración subcutánea de la combinación de dosis fija de Pertuzumab y Trastuzumab en participantes con cáncer de mama temprano positivo a HER2

... randomised multicentre, open-label, phase 2 trial. Lancet Oncology 2012;13(1):25-32. Gianni L, Pienkowski T, Im YH et al. 5-Year ... BO, Aft R et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Breast Cancer. Version I.2018 [internet]. ...

Ensayos Clínicos - ROCHE - 18/08/2021 - 5:58pm